HEAE.L vs. SPYL.L
HEAE.L (SPDR MSCI Europe Health Care UCITS ETF) and SPYL.L (SPDR S&P 500 UCITS ETF USD Acc) are both exchange-traded funds - HEAE.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while SPYL.L is a S&P 500 fund tracking the S&P 500. Both are passively managed. Over the past year, HEAE.L returned 9.06% vs 29.05% for SPYL.L. At a 0.25 correlation, their price movements are largely independent. HEAE.L charges 0.18%/yr vs 0.03%/yr for SPYL.L.
Performance
HEAE.L vs. SPYL.L - Performance Comparison
Loading charts...
Different Trading Currencies
HEAE.L is traded in GBP, while SPYL.L is traded in USD. To make them comparable, the SPYL.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, HEAE.L achieves a -2.42% return, which is significantly lower than SPYL.L's 10.73% return.
HEAE.L
- 1D
- 3.29%
- 1M
- 1.82%
- YTD
- -2.42%
- 6M
- -1.32%
- 1Y
- 9.06%
- 3Y*
- 2.88%
- 5Y*
- —
- 10Y*
- —
SPYL.L
- 1D
- 0.00%
- 1M
- 5.43%
- YTD
- 10.73%
- 6M
- 10.28%
- 1Y
- 29.05%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
HEAE.L vs. SPYL.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
HEAE.L SPDR MSCI Europe Health Care UCITS ETF | -2.42% | 13.38% | -1.21% | 4.94% |
SPYL.L SPDR S&P 500 UCITS ETF USD Acc | 10.80% | 9.03% | 27.52% | 9.22% |
Correlation
The correlation between HEAE.L and SPYL.L is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Nov 1, 2023 | 0.25 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HEAE.L vs. SPYL.L — Risk / Return Rank
HEAE.L
SPYL.L
HEAE.L vs. SPYL.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR MSCI Europe Health Care UCITS ETF (HEAE.L) and SPDR S&P 500 UCITS ETF USD Acc (SPYL.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HEAE.L | SPYL.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.88 | ||
| Sortino ratioReturn per unit of downside risk | -2.40 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.45 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | 0.66 | 3.96 | -3.30 |
| Martin ratioReturn relative to average drawdown | 1.57 | 13.51 | -11.94 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HEAE.L | SPYL.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.54 | 2.42 | -1.88 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.14 | 1.55 | -1.41 |
Drawdowns
HEAE.L vs. SPYL.L - Drawdown Comparison
The maximum HEAE.L drawdown since its inception was -24.51%, which is greater than SPYL.L's maximum drawdown of -21.16%. Use the drawdown chart below to compare losses from any high point for HEAE.L and SPYL.L.
Loading charts...
Drawdown Indicators
| HEAE.L | SPYL.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -24.51% | -21.16% | -3.35% |
Max Drawdown (1Y)Largest decline over 1 year | -13.73% | -7.21% | -6.52% |
Max Drawdown (3Y)Largest decline over 3 years | -24.51% | — | — |
Current DrawdownCurrent decline from peak | -10.88% | -0.28% | -10.60% |
Average DrawdownAverage peak-to-trough decline | -7.69% | -2.95% | -4.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.78% | 2.13% | +3.65% |
Volatility
HEAE.L vs. SPYL.L - Volatility Comparison
SPDR MSCI Europe Health Care UCITS ETF (HEAE.L) has a higher volatility of 5.60% compared to SPDR S&P 500 UCITS ETF USD Acc (SPYL.L) at 3.48%. This indicates that HEAE.L's price experiences larger fluctuations and is considered to be riskier than SPYL.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HEAE.L | SPYL.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.60% | 3.48% | +2.12% |
Volatility (6M)Calculated over the trailing 6-month period | 12.12% | 8.60% | +3.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.79% | 11.82% | +4.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.28% | 14.13% | +2.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.28% | 14.13% | +2.15% |
HEAE.L vs. SPYL.L - Expense Ratio Comparison
HEAE.L has a 0.18% expense ratio, which is higher than SPYL.L's 0.03% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
HEAE.L vs. SPYL.L - Dividend Comparison
Neither HEAE.L nor SPYL.L has paid dividends to shareholders.
Frequently Asked Questions
HEAE.L and SPYL.L have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SPYL.L is cheaper at 0.03% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SPYL.L is cheaper with a 0.03% expense ratio, compared with 0.18% for HEAE.L.
HEAE.L is categorized as Health & Biotech Equities, while SPYL.L is S&P 500. HEAE.L tracks MSCI World/Health Care NR USD, while SPYL.L tracks S&P 500. Their fees differ too: 0.18% for HEAE.L and 0.03% for SPYL.L.
Find the right allocation for HEAE.L and SPYL.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer